![](/img/cover-not-exists.png)
ANALYSIS OF THE LONG-TERM COSTS, SAVINGS AND EFFECTS GENERATED BY INFLIXIMAB TO NORMALIZE QUALITY OF LIFE IN PATIENTS WITH CROHN'S DISEASE
L Annemans, K Moeremans, P Rutgeerts, L LemmensVolume:
4
Year:
2001
Language:
english
DOI:
10.1046/j.1524-4733.2001.40202-157.x
File:
PDF, 999 KB
english, 2001